# Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI

> **NCT05101018** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Osteoporosis
- Spinal Cord Injuries

## Interventions

- **DRUG:** Romosozumab
- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT05101018
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101018, "Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05101018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*